🔗 Share this article Key US Advisory Committee to Cast Ballots on Modifying Newborn Hepatitis B Vaccine Guideline Following a delay and a particularly heated gathering, a government vaccine expert group was scheduled to decide on Friday regarding a potential change to the enduring advisory that each baby be immunized against hepatitis B. Heated Debate and a Delayed Ballot The opening session of the meeting on Thursday was characterized by heated debate over curbing eligibility to the hepatitis B vaccine for infants and a choice to delay the ballot by a day to give members more time to examine the language. The group, which advises the Centers for Disease Control and Prevention on immunization practices, had put off the vote twice in the past. “Is there any specific evidence of injury of giving this immunization before 30 days? Or is this speculation?” inquired one panel member. In reply, another participant stated, “There is inadequate data about the long-term risk.” Existing Recommendations and Possible Consequences The injection is presently advised for every newborn within 24 hours of birth to halt contraction of hepatitis B, which can cause serious liver damage. It has been provided to over a billion individuals for over thirty years. The meeting in Atlanta presented no new evidence of injuries resulting from the vaccine. Authorities state any change to the existing hepatitis B vaccination schedule could have major and extensive implications for pediatric well-being in the United States. Committee Makeup and New Appointments The advisory panel can only provide advice to the leader of the CDC. The committee's composition has experienced alterations recently, with the statement that the panel's latest chairman would step down for an official role and be succeeded by a cardiologist who has been critical of other immunizations. The committee includes a number of immunization doubters who are in agreement with a aim to revamp – and perhaps, in some cases, scrap – longstanding immunization guidelines.